SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

FIPB approves 10 FDI proposals worth Rs 2,858 crore

26 Mar 2015 Evaluate

The Foreign Investment Promotion Board (FIPB) has cleared 10 FDI proposals worth Rs 2,858 crore. The inter-governmental panel, chaired by Economic Affairs Secretary Rajiv Mehrishi, also cleared the pharma firm IPCA Laboratories' proposal to hike foreign institutional investment (FII) to 35 per cent entailing an investment of Rs 900 crore.

As the FDI proposals under approval route are cleared by the FIPB, while those worth above Rs 1,200 crore are given final clearance by the Cabinet Committee on Economic Affairs (CCEA), the proposal of Ambuja Cements for acquisition of 24 per cent shares in its holding company Holcim (India) for a share swap worth Rs 3,500 crore was referred to the CCEA.

The major proposals which got approval were of Reckitt Benckiser (India) to acquire 24.88% share of Reckitt Benckiser Healthcare India from its foreign investor, resulting in a foreign fund outflow of Rs 750 crore. Bangalore-based pharma firm Syngene International's proposal to inject Rs 380 crore into the company through 10% foreign equity participation has also been cleared. Biogenomics proposal to increase the foreign equity to 92.28% from 74% of the existing foreign shareholders by further infusion of capital amounting to Rs 75 crore too got FIPB’s nod along with Air Works India (Engineering) proposal for increasing foreign equity investment worth Rs 40 crore; while Ostro Energy's proposal to invest Rs 1,400 crore over four-five years in wind energy assets in India via downstream investment was approved earlier.

FIPB has deferred 18 proposals including that of Sharekhan for transfer of compulsory convertible debentures (CCDs) and compulsory convertible preference shares (CCPs), held by IDFC to Baring Private Equity.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: